Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-07

Clinical Trial Update: Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing 10 mg teduglutide in subjects with renal impairment to healthy individuals with normal renal function; study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teduglutide (teduglutide)

Snippet

Sponsor: Nycomed | Conditions: Renal Impairment | Phase 1 | Status: COMPLETED